Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose
Circular	Director General	66	20-6-2025	Regarding Specialized Mental Health Medications	Circular number 66: Concerning Specialized Mental Health Medications

ATC	Name	B/G	Ingredients	Form	Price
L03AX03	BCG-MEDAC	G	BCG seed RIVM derived from seed 1173-P2 - 2x10? to 3x10? viable units	Injectable powder for suspension+diluent	18,750,588 L.L
A11EA	BECOZYME	B	Vitamin B5 - 6mg/2ml, Vitamin B6 - 4mg/2ml, Vitamin PP - 40mg/2ml, Vitamin B2 - 5.47mg/2ml, Vitamin B1 - 10mg/2ml	Injectable solution	662,514 L.L
A11EX	BECOZYM FORTE	B	Nicotinamide - 50mg, Calcium Pantothenate - 25mg, Biotin - 0.15mg, Vitamin B12 - 10mcg, Vitamin B6 - 10mg, Vitamin B2 - 15mg, Vitamin B1 - 15mg	Capsule	290,270 L.L
C09DA06	BLOPRESS PLUS 16MG	B	Candesartan cilexetil - 16mg, Hydrochlorothiazide - 12.5mg	Tablet	1,257,837 L.L
C09DA06	BLOPRESS PLUS 8MG	B	Candesartan cilexetil - 8mg, Hydrochlorothiazide - 12.5mg	Tablet	1,060,292 L.L
C07AB12	BLOVEK	G	Nebivolol HCl - 5mg	Tablet	511,940 L.L
A03CA02	BIPAX	G	Clidinium bromide - 2.5mg, Chlordiazepoxide - 5mg	Tablet, sugar coated	363,477 L.L
R03AK07	BUFOMIX EASYHALER	G	Formoterol fumarate dihydrate - 4.5mcg/inhalation, Budesonide - 160mcg/inhalation	Metered dose inhaler	2,365,163 L.L
R03AK07	BUFOMIX EASYHALER	G	Formoterol fumarate dihydrate - 4.5mcg/inhalation, Budesonide - 160mcg/inhalation	Metered dose inhaler	1,182,581 L.L
R03AK07	BUFOMIX EASYHALER	G	Formoterol fumarate dihydrate - 9mcg, Budesonide - 320mcg	Metered dose inhaler	2,365,163 L.L
C07BB07	BISCORDEX PLUS	G	Bisoprolol fumarate - 5mg, Hydrochlorothiazide - 12.5mg	Tablet	723,115 L.L
C07BB07	BISOCOR 5 PLUS	G	Bisoprolol - 5mg, Hydrochlorothiazide - 12.5mg	Tablet, film coated	678,321 L.L
R03AK13	BUTOSOL	G	Salbutamol (sulfate) - 100mcg/dose, Beclometasone dipropionate - 50mcg/dose	Metered dose inhaler	548,288 L.L
D03AX	BEPANTHEN PLUS	B	Chlorhexidine HCl - 5mg/g, Dexpanthenol - 50mg/g	Cream	319,835 L.L
R03AL11	BREZTRI AEROSPHERE	B	Formoterol fumarate dihydrate - 5mcg, Glycopyrronium Bromide - 7.2mcg, Budesonide - 160mcg	Inhalation suspension	6,705,774 L.L
D05AX52	BETA-CAL	G	Calcipotriol (monohydrate) - 50mcg/g, Betamethasone (dipropionate) - 0.5mg/g	Ointment	1,574,983 L.L
D05AX52	BETA-CAL	G	Calcipotriol (monohydrate) - 50mcg/g, Betamethasone (dipropionate) - 0.5mg/g	Gel	1,251,117 L.L
D06AX	BANEOCIN	B	Neomycin sulfate - 5000IU/g, Bacitracin zinc - 250IU/g	Ointment	173,356 L.L
D06AX	BATRAMYCIN	B	Neomycin (sulfate) - 5000IU/g, Bacitracin - 250IU/g	Ointment	249,955 L.L
L03AX03	BCG-MEDAC	G	BCG seed RIVM derived from seed 1173-P2 - 2x10? to 3x10? viable units	Injectable powder for suspension+diluent	L.L
J01EE01	BACTRIM FORTE	B	Trimethoprim - 160mg, Sulfamethoxazole - 800mg	Tablet	344,024 L.L

Laws and Regulations